Eran Ophir
CIK: 0001972103
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
COMPUGEN LTD
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jul 29, 2026CGEN
COMPUGEN LTD
Award(A)DirectShare Option (right to buy)
200K shares- - Apr 24, 2026CGEN
COMPUGEN LTD
Sale(S)Direct5K shares at avg. $3.20$16K - Apr 24, 2026CGEN
COMPUGEN LTD
Exercise(M)Direct5K shares at avg. $0.83$4K - Apr 14, 2026CGEN
COMPUGEN LTD
Sale(S)Direct5K shares at avg. $2.90$15K - Apr 14, 2026CGEN
COMPUGEN LTD
Exercise(M)Direct5K shares at avg. $0.83$4K - Apr 1, 2026CGEN
COMPUGEN LTD
Exercise(M)Direct5.6K shares at avg. $0.83$5K - Apr 1, 2026CGEN
COMPUGEN LTD
Sale(S)Direct5.6K shares at avg. $2.21$12K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 29, 2026 | CGEN COMPUGEN LTD | Award(A) Share Option (right to buy) | 200,000 | - | - | Direct |
| Apr 24, 2026 | CGEN COMPUGEN LTD | Sale(S) | 5,000 | $3.20 | $16,001 | Direct |
| Apr 24, 2026 | CGEN COMPUGEN LTD | Exercise(M) | 5,000 | $0.83 | $4,146 | Direct |
| Apr 14, 2026 | CGEN COMPUGEN LTD | Sale(S) | 5,000 | $2.90 | $14,521 | Direct |
| Apr 14, 2026 | CGEN COMPUGEN LTD | Exercise(M) | 5,000 | $0.83 | $4,146 | Direct |
| Apr 1, 2026 | CGEN COMPUGEN LTD | Exercise(M) | 5,625 | $0.83 | $4,664 | Direct |
| Apr 1, 2026 | CGEN COMPUGEN LTD | Sale(S) | 5,625 | $2.21 | $12,413 | Direct |
1-7 of 7 transactions
About Ophir Eran
Ophir Eran (SEC CIK 0001972103) files insider reports with the SEC as President and CEO of COMPUGEN LTD (CGEN).
Signal8 holds 5 ownership filings by Ophir Eran (1 Form 3, 4 Form 4), filed between Mar 18, 2026 and Jul 30, 2026. Those filings report 7 transactions, from Apr 1, 2026 to Jul 29, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Ophir Eran's filings is in HOLON.
Recent filings by Ophir Eran
- Jul 29, 2026: Grant or award of CGEN derivative securities (Form 4, code A).
- Apr 24, 2026: Open-market sale of CGEN shares (Form 4, code S).
- Apr 24, 2026: Option exercise of CGEN shares (Form 4, code M).
- Apr 14, 2026: Open-market sale of CGEN shares (Form 4, code S).
- Apr 14, 2026: Option exercise of CGEN shares (Form 4, code M).
Other insiders filing for COMPUGEN LTD (CGEN)
- Levine Zurit, SVP, Business Development
- Silberman David, Chief Financial Officer
- Cohen-Dayag Anat, Director
- Perry Eran, Director
- Ferre Pierre, Chief Operating Officer
- Kredo Russo Sharon, SVP, Research & Discovery